Among nearly 850,000 veterans newly diagnosed with PTSD, starting CPT/PE treatment was linked with a 23% lower suicide risk compared with not starting treatment (HR 0.77, 95% CI 0.59-0.99 ...

Despite guidelines recommending other anticoagulants for people hospitalized with acute pulmonary embolism (PE), old habits ...

AngioDynamics, Inc. (ANGO), a New York-based medical technology company Monday announced the publication of results from the Acute ...

MARIA, a 42-year-old teacher with an energetic spirit, had always been an active woman. However, one morning after a long ...

Data Synthesis: No placebo-controlled trials of anticoagulants as treatment of PE with objective criteria for diagnosis have been published. Three randomized trials of anticoagulants vs no ...

Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced completion of patient enrollment in its AVENTUS Clinical Trial, a pivotal Investigational Device ...

Inquis Medical announced today that it completed enrollment in a pivotal trial evaluating its Aventus thrombectomy system.

We are proud to enroll the first patient in the CLEAN-PE study utilizing the Cleaner™ Pro Thrombectomy system. Unique treatment options are emerging for the management of this patient population.

Lucie Quigley is all too familiar with the confusion, challenges and miscommunication that surround perimenopause. Now 52, ...

(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient ...